The anti-apoptotic effect of hypocretin on pancreatic beta-cells raises peripheral insulin sensitivity while decreasing lipolysis in adipose tissue, raising the risk of obesity and type 2 diabetes (T2D) in narcoleptic patients. Here, HCRT is linked to type 2 diabetes mellitus.